Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression

Oncogene
Ulrika WilhelmssonMilos Pekny

Abstract

In astrocytic neoplasms, the number of cells expressing glial fibrillary acidic protein (GFAP) is inversely proportional to the extent of anaplasia. The loss of GFAP expression, the principal marker of astroglial cells, in these tumors has been proposed to constitute a step in their development and progression. To test this hypothesis, we crossed p53-negative (p53(-/-)) mice, which frequently develop astrocytomas after intrauterine exposure to ethylnitrosourea, with GFAP-negative (GFAP(-/-)) mice or GFAP(+/+) controls. Brain tumors of glial origin were found in 12 of 35 GFAP(+/+) p53(-/-) mice (34%) and in 11 of 27 GFAP(-/-) p53(-/-) mice (41%). The two groups did not differ in the age at which tumors were detected or in tumor histology or progression. Thus, the loss of GFAP expression frequently seen in high-grade astrocytomas does not constitute a step in tumor development. Rather, it may represent the undifferentiated state of these cells.

References

Mar 1, 1979·Journal of the National Cancer Institute·C M JacqueN Baumann
Jul 1, 1978·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·L F Eng, L J Rubinstein
Jan 1, 1978·Journal of the Neurological Sciences·C M JacqueN A Baumann
Sep 1, 1992·Journal of the Neurological Sciences·C M Poser
Jan 1, 1990·Acta Neuropathologica·T OritaH Ito
Sep 15, 1973·International Journal of Cancer. Journal International Du Cancer·B Westermark
May 7, 1971·Brain Research·L F EngB Gerstl
Jul 21, 1999·Journal of Neurosurgery·O EngebraatenO Fodstad
Dec 6, 2000·Current Opinion in Pediatrics·W A Weiss
Aug 3, 2002·Nature Reviews. Cancer·Yuan Zhu, Luis F Parada

❮ Previous
Next ❯

Citations

Feb 11, 2005·Current Opinion in Gastroenterology·Julian R F Walters
Feb 21, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Peter B Dirks
Nov 18, 2010·Journal of Biomedical Science·Bhanu Iyengar, Avantika V Singh
Nov 7, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Jana VranovaJozef Rosina
Sep 25, 2010·Clinical Advances in Hematology & Oncology : H&O·Robert Becker, Elizabeth Mansfield
Jun 2, 2009·International Journal of Radiation Oncology, Biology, Physics·Christy M WilsonThomas E Merchant
Mar 10, 2016·Molecular Neurobiology·Saoussen TrabelsiDorra H'mida Ben Brahim
Apr 23, 2013·Journal of Experimental & Clinical Cancer Research : CR·Rui LiaoShuang-Jian Qiu
Sep 20, 2015·Progress in Neurobiology·Alexei VerkhratskyVedrana Montana
Jul 26, 2015·Molecular Neurobiology·Hardeep KatariaGurcharan Kaur
May 16, 2015·Seminars in Pediatric Neurology·Quincy QuickOmar Skalli
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter B Dirks
May 17, 2018·Journal of Neuro-oncology·Adrienn VolakCasey A Maguire
Nov 16, 2017·Cancer Biotherapy & Radiopharmaceuticals·Elena VasilskisHenry Engler
Nov 4, 2011·Journal of Neural Engineering·J P HarrisD J Tyler
Nov 6, 2018·IUBMB Life·Padmakrishnan C JayakrishnanSrinivas Gopala
Oct 22, 2019·Therapeutic Advances in Medical Oncology·Shih-Jung LiuYuan-Yun Tseng
Aug 18, 2021·Stem Cell Reviews and Reports·Isabele Cristiana IserMárcia Rosângela Wink

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.